COMMUNIQUÉ DE PRESSE publié le 24/05/2023 à 12:00, il y a 3 années 1 mois Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital
COMMUNIQUÉ DE PRESSE publié le 27/04/2023 à 12:00, il y a 3 années 2 mois Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Secured Convertible Debentures for Gross Proceeds of AUD$2,400,000
COMMUNIQUÉ DE PRESSE publié le 12/04/2023 à 22:00, il y a 3 années 2 mois Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
COMMUNIQUÉ DE PRESSE publié le 04/04/2023 à 12:00, il y a 3 années 2 mois Tryp Therapeutics Completes Psychotherapy Training for Planned Phase 2a Clinical Trial at Massachusetts General Hospital
COMMUNIQUÉ DE PRESSE publié le 05/01/2023 à 13:00, il y a 3 années 5 mois Tryp Therapeutics Announces Interim Results for Its Phase II Clinical Trial for the Treatment of Binge Eating Disorder With Psilocybin-Assisted Psychotherapy
COMMUNIQUÉ DE PRESSE publié le 03/01/2023 à 13:00, il y a 3 années 5 mois Tryp Therapeutics and Massachusetts General Hospital Sign Letter of Intent for Clinical Study Investigating the Use of Psilocybin-Assisted Psychotherapy for the Treatment of Patients Suffering From Irritable Bowel Syndrome (IBS)
Publié le 30/06/2026 à 07:30, il y a 6 heures 38 minutes Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Publié le 30/06/2026 à 07:30, il y a 6 heures 38 minutes Gimv cède sa participation dans AlpenBlu Clinics (précédemment Les Psy Réunis), acteur suisse des soins ambulatoires en santé mentale, à Impact Healthcare
Publié le 30/06/2026 à 07:00, il y a 7 heures 8 minutes bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
Publié le 30/06/2026 à 13:30, il y a 38 minutes Electric Metals Ore Sorting Assessment Indicates Potential to More Than Double Emily Manganese Feed Grade While Recovering 92% of Contained Manganese
Publié le 30/06/2026 à 13:30, il y a 38 minutes Orogen Royalties Announces Permitting Update for Portal Construction at Ermitaño's Navidad Deposit
Publié le 30/06/2026 à 13:15, il y a 53 minutes Silver Wolf Reports Contact Skarn Intercepts From the Ongoing Drill Program at the Ana Maria Property
Publié le 30/06/2026 à 13:00, il y a 1 heure 8 minutes Kalo Gold Confirms a Gold-Bearing Epithermal System at Wainikoro Over a Strike Length of 1.8 km, Vatu Aurum, Fiji
Publié le 30/06/2026 à 13:00, il y a 1 heure 8 minutes IBC Advanced Alloys Promotes Jenny Gipson to President of its Nonferrous Division
Publié le 30/06/2026 à 13:08, il y a 59 minutes Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): Under review
Publié le 30/06/2026 à 13:01, il y a 1 heure 6 minutes HMS Bergbau AG: Final Figures for Fiscal Year 2025 Published – Significant Earnings Growth and Positive Outlook
Publié le 30/06/2026 à 13:00, il y a 1 heure 8 minutes Gledhow Investments plc: First Half Results to 31 March 2026
Publié le 30/06/2026 à 12:59, il y a 1 heure 9 minutes EQS-Adhoc: Emerald Horizon AG: Management Board member and majority shareholder Florian Wagner commits to provide additional equity financing in the amount of EUR 20 million.
Publié le 30/06/2026 à 12:35, il y a 1 heure 32 minutes Eleving Group S.A. — Acquisition or disposal of the issuer's own shares
